Real-world implementation of diabetes management by pharmacists: The RXING Practice Tool - Yazid N. Al Hamarneh, Hiroshi Okada, Ross T. Tsuyuki, 2021
![Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary - Endocrine Practice Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary - Endocrine Practice](https://www.endocrinepractice.org/cms/attachment/5af1ff48-ac12-4f30-8063-d3f1c658e21c/gr1.jpg)
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary - Endocrine Practice
![The Lancet Commission on diabetes: using data to transform diabetes care and patient lives - The Lancet The Lancet Commission on diabetes: using data to transform diabetes care and patient lives - The Lancet](https://www.thelancet.com/cms/attachment/f9fc96ac-44c1-4c18-af90-c4e96d2ca1f6/gr1_lrg.jpg)
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives - The Lancet
Patient-reported outcomes for diabetes and hypertension care in low- and middle-income countries: A scoping review | PLOS ONE
![Self-monitoring of blood glucose in association with glycemic control in newly diagnosed non-insulin-treated diabetes patients: a retrospective cohort study | Scientific Reports Self-monitoring of blood glucose in association with glycemic control in newly diagnosed non-insulin-treated diabetes patients: a retrospective cohort study | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-81024-x/MediaObjects/41598_2021_81024_Fig1_HTML.png)
Self-monitoring of blood glucose in association with glycemic control in newly diagnosed non-insulin-treated diabetes patients: a retrospective cohort study | Scientific Reports
![The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults - The Lancet Healthy Longevity The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults - The Lancet Healthy Longevity](https://www.thelancet.com/cms/asset/b85ee27c-210f-4728-9b4d-d4ecee6a0fce/gr1.jpg)
The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults - The Lancet Healthy Longevity
![Advancing Diabetes Care - Module / MSc / PgCert / PgDip - 2023/24 Entry | Birmingham City University Advancing Diabetes Care - Module / MSc / PgCert / PgDip - 2023/24 Entry | Birmingham City University](https://bcu.imgix.net/advanced-diabetes-care-1-133137800743565948.jpg?auto=format&fm=jpg&q=80&fit=crop&crop=faces%2Ccenter&w=710&h=399)
Advancing Diabetes Care - Module / MSc / PgCert / PgDip - 2023/24 Entry | Birmingham City University
![New EASD-ADA consensus guidelines on managing hyperglycaemia in type 2 diabetes launched at EASD meeting. New recommendations include specific drug classes for some patients and enhancing medication adherence – Diabetologia New EASD-ADA consensus guidelines on managing hyperglycaemia in type 2 diabetes launched at EASD meeting. New recommendations include specific drug classes for some patients and enhancing medication adherence – Diabetologia](https://diabetologia-journal.org/wp-content/uploads/2018/09/Fig-2-for-EASD-ADA.jpg)
New EASD-ADA consensus guidelines on managing hyperglycaemia in type 2 diabetes launched at EASD meeting. New recommendations include specific drug classes for some patients and enhancing medication adherence – Diabetologia
![Health Care Access and Use Among Adults with Diabetes During the COVID-19 Pandemic — United States, February–March 2021 | MMWR Health Care Access and Use Among Adults with Diabetes During the COVID-19 Pandemic — United States, February–March 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7046a2_DiabetesCOVIDCareGaps_IMAGE_19Nov21_1200x627_v2.jpg)